Radiomics Features Predicting Outcomes of PAD
Key facts
- Who runs it
- Zhijun Bao
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 200 people, planned
- Started
- 1 Apr 2026
- Expected to end
- 31 Dec 2026
- Type of study
- Observational
- Treatments tested
- Non interventional study
- Record updated
- 22 May 2026
Who can take part
- Age
- 18 years to 100 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- aged between 18 and 100 years
- meeting the diagnostic criteria for peripheral artery disease (PAD)
- successfully undergoing interventional surgery
- successfully completing preoperative lower limb CTA or MRA examination with good image quality, suitable for radiomics analysis
Who cannot take part
- Heart failure (NYHA class III/IV)
- right-to-left shunt heart disease
- severe aortic and mitral valve insufficiency
- acute coronary syndrome, or malignant arrhythmia
- severe pulmonary hypertension (pulmonary artery pressure >90mmHg)
- any allergic constitution
- moderate to severe renal insufficiency (creatinine clearance rate <60ml/min)
- pregnancy and childbirth period
- life expectancy <12 months
- poor image quality, unable to analyze
- incomplete medical history data
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
There is a high risk of restenosis and vascular occlusion after interventional treatment for peripheral arterial disease (PAD), and some severe patients inevitably end up with amputation. Perivascular adipose tissue (PVAT) has been recognized not only as an inert tissue providing mechanical support, but also as a highly active endocrine and paracrine organ, which could provide a new imaging perspective into the pathophysiological mechanism of lower limb atherosclerosis microenvironment. The aim of this study is to identify novel and reliable non-invasive imaging biomarkers by exploring the potential association between lower limb PVAT imaging omics features and clinical outcomes (including death, major amputation, target vessel revascularization, etc.) in patients with PAD after interventional treatment. The study aims to offer clinicians with more accurate personalized risk stratification tools before surgery, thereby optimizing clinical decision-making and helping to achieve precision medicine for PAD.
The group in the trial
- patients of peripheral artery disease
patients of peripheral artery disease after intervention
Treatment: Non interventional study
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Radiomics Features for Predicting Clinical Outcomes in Peripheral Artery Disease
- Record updated
- 22 May 2026